Bird & Bird advised Fonds Patient Autonome and Uniqa Ventures on their €4 million financing round of Fizimed

International law firm Bird & Bird advised Fonds Patient Autonome, managed by Bpifrance, and Uniqa Ventures on their participation in the €4 million financing round of Fizimed, a femtech dedicated to women's health.

The Fonds Patient Autonome and Uniqa Ventures led the financing round, in which UI Investissement also participated.

The Bird & Bird team advising Fonds Patient Autonome and Uniqa Ventures comprised of partner Carole Bodin and associate Pascaline Sagot, who advised on the corporate aspects, with partner Alexandre Vuchot and associate Caroline Arrighi-Savoie advising on the regulatory aspects.

The company was advised by Charles Russell Speechlys. The team comprised of partner Renaud Ferry and Counsel Orlando Vignoli Neto.

News & Deals

More News & Deals
Deal Bird & Bird advises Brose Sitech on the acquisition of Proseat including its subsidiaries from Sekisui Kasei

Jul 07 2025

Read More
News Bird & Bird strengthens market-leading patent practice with Anna Wolters-Höhne in Hamburg

Jul 07 2025

Read More
News Bird & Bird acts for Willis Mitsui & Co Engine Support Limited in Acquisition of Bridgend Asset Management Limited

Jul 04 2025

Read More
News Bird & Bird partner Bill Smith relocates to the Middle East to head the Dispute Resolution practice

Jul 02 2025

Read More
News Bird & Bird boosts Commercial team in Sweden with new partner Mårten Lindberg

Jul 01 2025

Read More
News Bird & Bird advises Gprnt on seed funding round

Jun 27 2025

Read More